Morgan Stanley’s Fractyl Health GUTS Stock Holding History

Morgan Stanley’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Sell	35,542 -5,783	-14%	-$49.4K	﹤0.01%	5725
2026 Q1	$227K	Sell	41,325 -13,382	-24%	-$148K	﹤0.01%	5820
2025 Q4	$1.44M	Buy	54,707 +18,854	+53%	+$364K	﹤0.01%	4998
2025 Q3	$684K	Buy	35,853 +22,779	+174%	+$355K	﹤0.01%	5354
2025 Q2	$254K	Sell	13,074 -263	-2%	-$5.1K	﹤0.01%	5757
2025 Q1	$190K	Sell	13,337 -9,232	-41%	-$177K	﹤0.01%	5748
2024 Q4	$558K	Buy	22,569 +8,629	+62%	+$241K	﹤0.01%	5375
2024 Q3	$423K	Buy	13,940 +7,860	+129%	+$308K	﹤0.01%	5478
2024 Q2	$312K	Sell	6,080 -17,132	-74%	-$1.32M	﹤0.01%	5492
2024 Q1	$2.06M	Buy	+23,212	New	+$2.35M	﹤0.01%	4551

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley's GUTS Position: Q2 2026 in Review

Morgan Stanley reduced its Fractyl Health (GUTS) stake by 14% in Q2 2026, selling an estimated $49.4K and leaving 35,542 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #5725.

Morgan Stanley first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.06M in Q1 2024. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Morgan Stanley held 35,542 shares of Fractyl Health worth $339K as of Q2 2026.
Morgan Stanley sold 5,783 Fractyl Health shares in Q2 2026, an estimated $49.4K.
Fractyl Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5725 holding.
Morgan Stanley first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
Morgan Stanley's Fractyl Health position peaked at $2.06M in Q1 2024.
79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.